Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments.

Busquets O, Ettcheto M, Eritja À, Espinosa-Jiménez T, Verdaguer E, Olloquequi J, Beas-Zarate C, Castro-Torres RD, Casadesús G, Auladell C, Bulló M, Folch J, Camins A.

J Mol Med (Berl). 2019 Dec;97(12):1723-1733. doi: 10.1007/s00109-019-01856-z. Epub 2019 Dec 3.

PMID:
31797011
2.

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia.

Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A.

Front Aging Neurosci. 2019 Sep 6;11:236. doi: 10.3389/fnagi.2019.00236. eCollection 2019.

3.

Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology?

Grizzanti J, Corrigan R, Servizi S, Casadesus G.

J Neurol Neuromedicine. 2019;4(1):12-16. doi: 10.29245/2572.942X/2019/1.1212. Epub 2019 Feb 10.

4.

Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.

Patrick S, Corrigan R, Grizzanti J, Mey M, Blair J, Pallas M, Camins A, Lee HG, Casadesus G.

J Alzheimers Dis. 2019;69(1):157-168. doi: 10.3233/JAD-180421.

5.

CNS luteinizing hormone receptor activation rescues ovariectomy-related loss of spatial memory and neuronal plasticity.

Blair JA, Bhatta S, Casadesus G.

Neurobiol Aging. 2019 Jun;78:111-120. doi: 10.1016/j.neurobiolaging.2019.02.002. Epub 2019 Feb 13.

PMID:
30925299
6.

Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen Loss.

Bhatta S, Blair JA, Casadesus G.

Front Endocrinol (Lausanne). 2018 Sep 24;9:544. doi: 10.3389/fendo.2018.00544. eCollection 2018. Review.

7.

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.

Grizzanti J, Corrigan R, Casadesus G.

J Alzheimers Dis. 2018;66(1):11-23. doi: 10.3233/JAD-180433. Review.

8.

Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Ettcheto M, Sánchez-López E, Gómez-Mínguez Y, Cabrera H, Busquets O, Beas-Zarate C, García ML, Carro E, Casadesus G, Auladell C, Vázquez Carrera M, Folch J, Camins A.

Mol Neurobiol. 2018 Sep;55(9):7327-7339. doi: 10.1007/s12035-018-0868-4. Epub 2018 Feb 5.

PMID:
29404958
9.

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.

Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesús G, Beas-Zarate C, Pelegri C, Vilaplana J, Auladell C, Camins A.

J Alzheimers Dis. 2018;62(3):1223-1240. doi: 10.3233/JAD-170672. Review.

10.

Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease.

Ettcheto M, Abad S, Petrov D, Pedrós I, Busquets O, Sánchez-López E, Casadesús G, Beas-Zarate C, Carro E, Auladell C, Olloquequi J, Pallàs M, Folch J, Camins A.

Mol Neurobiol. 2018 Jun;55(6):4885-4895. doi: 10.1007/s12035-017-0690-4. Epub 2017 Jul 27.

PMID:
28752224
11.

Experimental Models for Aging and their Potential for Novel Drug Discovery.

Folch J, Busquets O, Ettcheto M, Sánchez-López E, Pallàs M, Beas-Zarate C, Marin M, Casadesus G, Olloquequi J, Auladell C, Camins A.

Curr Neuropharmacol. 2018;16(10):1466-1483. doi: 10.2174/1570159X15666170707155345. Review.

12.

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Grizzanti J, Lee HG, Camins A, Pallas M, Casadesus G.

Nutr Res. 2016 Dec;36(12):1305-1315. doi: 10.1016/j.nutres.2016.11.002. Epub 2016 Nov 8. Review.

13.

Correction: Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation.

Blair JA, Wang C, Hernandez D, Siedlak SL, Rodgers MS, Achar RK, Fahmy LM, Torres SL, Petersen RB, Zhu X, Casadesus G, Lee HG.

PLoS One. 2016 Jun 3;11(6):e0157209. doi: 10.1371/journal.pone.0157209. eCollection 2016.

14.

Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation.

Blair JA, Wang C, Hernandez D, Siedlak SL, Rodgers MS, Achar RK, Fahmy LM, Torres SL, Petersen RB, Zhu X, Casadesus G, Lee HG.

PLoS One. 2016 Mar 16;11(3):e0151615. doi: 10.1371/journal.pone.0151615. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0157209.

15.

Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.

Blair JA, Palm R, Chang J, McGee H, Zhu X, Wang X, Casadesus G.

Horm Behav. 2016 Feb;78:60-6. doi: 10.1016/j.yhbeh.2015.10.013. Epub 2015 Oct 21.

16.

Luteinizing hormone: Evidence for direct action in the CNS.

Blair JA, Bhatta S, McGee H, Casadesus G.

Horm Behav. 2015 Nov;76:57-62. doi: 10.1016/j.yhbeh.2015.06.020. Epub 2015 Jul 12. Review.

17.

High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents.

Petrov D, Pedrós I, Artiach G, Sureda FX, Barroso E, Pallàs M, Casadesús G, Beas-Zarate C, Carro E, Ferrer I, Vazquez-Carrera M, Folch J, Camins A.

Biochim Biophys Acta. 2015 Sep;1852(9):1687-99. doi: 10.1016/j.bbadis.2015.05.004. Epub 2015 May 21.

18.

Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogen.

Blair JA, McGee H, Bhatta S, Palm R, Casadesus G.

Front Endocrinol (Lausanne). 2015 Mar 25;6:45. doi: 10.3389/fendo.2015.00045. eCollection 2015. Review.

19.

From Neurodegeneration to Brain Health: An Integrated Approach.

Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz WK, Wang Y, Whitehouse P, Lerner A.

J Alzheimers Dis. 2015;46(1):271-83. doi: 10.3233/JAD-150043. Review.

PMID:
25720413
20.

Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.

Pedrós I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, Auladell C, Pallàs M, Vázquez-Carrera M, Casadesús G, Folch J, Camins A.

Biochim Biophys Acta. 2014 Sep;1842(9):1556-66. doi: 10.1016/j.bbadis.2014.05.025. Epub 2014 Jun 2.

Supplemental Content

Loading ...
Support Center